Diabetology & Metabolic Syndrome (Aug 2021)

Human Leukocyte Antigens class II (HLA II) gene profile from an admixed population of patients with type 1 diabetes with severe diabetic retinopathy: a nested case-control study in Brazil

  • Deborah Conte Santos,
  • Luís Cristóvão Porto,
  • Marcela Haas Pizarro,
  • Laura Gomes Nunes de Melo,
  • Dayse A. Silva,
  • Romulo Vianna Oliveira,
  • Anna Paula Villela,
  • Luiza Harcar Muniz,
  • Camila Soares,
  • Lucianne Righeti Monteiro Tannus,
  • Karla Rezende Guerra Drummond,
  • André Araújo Pinheiro,
  • Felipe Mallmann,
  • Franz Schubert Lopes Leal,
  • Fernando Korn Malerbi,
  • Paulo Henrique Morales,
  • Marília Brito Gomes

DOI
https://doi.org/10.1186/s13098-021-00702-y
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background Although the well-established role of the HLA genes on the predisposition of type 1 diabetes (T1D), its contribution to the development and progression of diabetic retinopathy is still unclear, especially in admixed populations. We aimed to study the relationship between HLA alleles and severe diabetic retinopathy in a highly admixed population of T1D patients. Methods This was a nested case-control study based on a cross-sectional, nationwide survey conducted in Brazil. We included 117 patients with severe diabetic retinopathy and 117 random controls composed of T1D patients without retinopathy, matched for diabetes duration. HLA-class II genes (HLA-DRB1, -DQA1, and -DQB1) were genotyped using the SSO and NGS methods. Results Haplotypes HLA-DRB1*04:05 ~ DQA1*03:01 g ~ DQB1*03:02 (OR 1.75, CI 0.97–3.16, p value 0.058) and HLA-DRB1*13:02 ~ DQA1*01:02 ~ DQB1*06:04 (OR 5.18, CI 1.12–23.09, p value 0.019) were more prevalent on the severe DR group but they did not present statistically difference after Bonferroni correction. The most frequent haplotype on both groups was HLA-DRB1*03:01 ~ DQA1*05:01 g ~ DQB1*02:01 (29.6% on severe DR and 33.33% on the control group). Conclusions Our study showed no influence of HLA genes on the development of DR. Further longitudinal data is needed to better understand the role of genetic factors on this multifactorial significant microvascular complication.

Keywords